An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.
25 August 2023 (17:15 - 17:45)
Organised by: 
About the speaker
Saint Vincenz Hospital Paderborn, Paderborn (Germany)
4 More presentations in this session
Doctor B. MacDonald (Vancouver, CA)
Doctor M. Walli-Attaei (Oxford, GB)
Mr A. Holt (Copenhagen, DK)
Miss J. Liang (Auckland, NZ)
Access the full session
The Event
ESC Congress 2023
25 August 2023
17:15 CET
